Analysis of the regulatory motifs in eukaryotic initiation factor 4E-binding protein 1

FEBS Journal

Volumn 275, Issue 9, 2008, Pages 2185-2199

  Lee, Vivian H Y ^a   Healy, Timothy ^a   Fonseca, Bruno D ^a   Hayashi, Amanda ^b   Proud, Christopher G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

4E BP1; mTOR; mTORC1; RAIP motif; TOS motif

Indexed keywords

INITIATION FACTOR 4E BINDING PROTEIN 1; ISOLEUCINE; MAMMALIAN TARGET OF RAPAMYCIN; PHENYLALANINE; PROLINE;

ARTICLE; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARGININE; CARRIER PROTEINS; CELL LINE; EUKARYOTIC INITIATION FACTOR-4E; GLUTATHIONE TRANSFERASE; HUMANS; ISOLEUCINE; KIDNEY; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASES; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EUKARYOTA; MAMMALIA; RAPTORES; TOSCANA VIRUS;

EID: 42449136578     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2008.06372.x     Document Type: Article

References (40)

1. Wullschleger S, Loewith R Hall MN (2006) TOR signaling in growth and metabolism. Cell 124, 471 484.
2. Sabatini DM (2006) mTOR and cancer: insights into a complex relationship. Nat Rev Cancer 6, 729 734.
3. Kim DH, Sarbassov D, Ali SM, King JE, Latek RR, Erdjument-Bromage H, Tempst P Sabatini DM (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163 175.
4. Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S, Tokunaga C, Avruch J Yonezawa K (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177 189.
5. Choi K-M, McMahon LP Lawrence JC (2003) Two motifs in the translational repressor PHAS-I required for efficient phosphorylation by mammalian target of rapamycin and for recognition by raptor. J Biol Chem 278, 19667 19673.
6. Nojima H, Tokunaga C, Eguchi S, Oshiro N, Hidayat S, Yoshino K, Hara K, Tanaka J, Avruch J Yonezawa K (2003) The mTOR partner, raptor, binds the mTOR substrates, p70 S6 kinase and 4E-BP1, through their TOS (TOR signaling) motifs. J Biol Chem 278, 15461 15464.
7. Schalm SS, Fingar DC, Sabatini DM Blenis J (2003) TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function. Curr Biol 13, 797 806.
8. Kim DH Sabatini DM (2004) Raptor and mTOR: subunits of a nutrient-sensitive complex. Curr Top Microbiol Immunol 279, 259 270.
9. Manning BD Cantley LC (2003) Rheb fills a GAP between TSC and TOR. Trends Biochem Sci 28, 573 576.
10. Long X, Lin Y, Ortiz-Vega S, Yonezawa K Avruch J (2005) Rheb binds and regulates the mTOR kinase. Curr Biol 15, 702 713.
11. McManus EJ Alessi DR (2002) TSC1-TSC2: a complex tale of PKB-mediated S6K regulation. Nat Cell Biol 4, E214 E216.
12. Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC Blenis J (2002) Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci USA 99, 13571 13576.
13. Inoki K, Li Y, Xu T Guan KL (2003) Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 17, 1829 1834.
14. Tee AR, Anjum R Blenis J (2003) Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin. J Biol Chem 278, 37288 37296.
15. Zhang Y, Gao X, Saucedo LJ, Ru B, Edgar BA Pan D (2003) Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat Cell Biol 5, 578 581.
16. Cai SL, Tee AR, Short JD, Bergeron JM, Kim J, Shen J, Guo R, Johnson CL, Kiguchi K Walker CL (2006) Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J Cell Biol 173, 279 289.
17. Bai X, Ma D, Liu A, Shen X, Wang QJ, Liu Y Jiang Y (2007) Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38. Science 318, 977 980.
18. Schalm SS Blenis J (2002) Identification of a conserved motif required for mTOR signaling. Curr Biol 12, 632 639.
19. Beugnet A, Wang X Proud CG (2003) The TOR-signaling and RAIP motifs play distinct roles in the mTOR-dependent phosphorylation of initiation factor 4E-binding protein 1 in vivo. J Biol Chem 278, 40717 40722.
20. Wang X Proud CG (2006) The mTOR pathway in the control of protein synthesis. Physiology (Bethesda) 21, 362 369.
21. Land SC Tee AR (2007) Hypoxia inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR-signalling motif. J Biol Chem 282, 20534 20543.
22. Wang L, Harris TE, Roth RA Lawrence JC (2007) PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. J Biol Chem 282, 20036 20044.
23. Oshiro N, Takahashi R, Yoshino KI, Tanimura K, Nakashima A, Eguchi S, Miyamoto T, Hara K, Takehana K, Avruch J et al. (2007) The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mTOR complex 1. J Biol Chem 282, 20329 20339.
24. Fonseca BD, Smith EM, Lee VH, MacKintosh C Proud CG (2007) PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex. J Biol Chem 282, 24514 24524.
25. Tee AR Proud CG (2002) Caspase cleavage of initiation factor 4E-binding protein 1 yields a dominant inhibitor of cap-dependent translation and reveals a novel regulatory motif. Mol Cell Biol 22, 1674 1683.
26. Gingras A-C, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, Aebersold R Sonenberg N (1999) Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev 13, 1422 1437.
27. Mothe-Satney I, Yang D, Fadden P, Haystead TAJ Lawrence JC (2000) Multiple mechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression. Mol Cell Biol 20, 3558 3567.
28. Mothe-Satney I, Brunn GJ, McMahon LP, Capaldo CT, Abraham RT Lawrence JC (2000) Mammalian target of rapamycin-dependent phosphorylation of PHAS-1 in four (S/T)P sites detected by phospho-specific antibodies. J Biol Chem 275, 33836 33843.
29. Wang X, Beugnet A, Murakami M, Yamanaka S Proud CG (2005) Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins. Mol Cell Biol 25, 2558 2572.
30. Mader S, Lee H, Pause A Sonenberg N (1995) The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4gamma and the translational repressors 4E-binding proteins. Mol Cell Biol 15, 4990 4997.
31. Eguchi S, Tokunaga C, Hidayat S, Oshiro N, Yoshino K, Kikkawa U Yonezawa K (2006) Different roles for the TOS and RAIP motifs of the translational regulator protein 4E-BP1 in the association with raptor and phosphorylation by mTOR in the regulation of cell size. Genes Cells 11, 757 766.
32. Fletcher CM, McGuire AM, Gingras A-C, Li H, Matsuo H, Sonenberg N Wagner G (1998) 4E binding proteins inhibit the translation factor eIF4E without folded structure. Biochemistry 37, 9 15.
33. Wang X, Li W, Parra J-L, Beugnet A Proud CG (2003) The C-terminus of initiation factor 4E-binding protein 1 contains multiple regulatory features that influence its function and phosphorylation. Mol Cell Biol 23, 1546 1557.
34. Gingras A-C, Raught B, Gygi SP, Niedzwieka A, Miron M, Burley SK, Polakiewicz RD, Wyslouch-Cieczyska A, Aebersold R Sonenberg N (2001) Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev 15, 2852 2864.
35. Yokogami K, Wakisaka S, Avruch J Reeves SA (2000) Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr Biol 10, 47 50.
36. Fang P, Hwa V Rosenfeld RG (2006) Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway. Exp Cell Res 312, 1229 1239.
37. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P Parker PJ (1998) Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281, 2042 2045.
38. Parekh D, Ziegler W, Yonezawa K, Hara K Parker PJ (1999) Mammalian TOR controls one of two kinase pathways acting upon PKCdelta and epsilon. J Biol Chem 274, 34758 34764.
39. Scheper GC, Parra J-L, Wilson ML, van Kollenburg B, Vertegaal ACO, Han Z-G Proud CG (2003) The N and C termini of the splice variants of the human mitogen-activated protein kinase-interacting kinase Mnk2 determine activity and localization. Mol Cell Biol 23, 5692 5705.
40. Waskiewicz AJ, Flynn A, Proud CG Cooper JA (1997) Mitogen-activated kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J 16, 1909 1920.